|
Friday 23rd August 2002 |
Text too small? |
AMP has a heavy exposure to the British sharemarket, where insurers have suffered from heavy falls. That exposure was the biggest factor in a $A6 million loss from investment activities.
The result was in line with analysts' expectations following two consecutive profit warnings. Since March AMP's share price has fallen 26% to $A14.
AMP's "core recurring operating margins" rose 3% to $A470 million but the company said markets would remain "difficult."
No comments yet
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m